Login  
 
            ANABOLIC STEROIDS       HGH & PEPTIDES       Ocandrolic/50mg       PROTECTION       SEX       SPECIAL OFFER       STEROIDS       WEIGHT LOSS      
 
ANABOLIC STEROIDS

Alphabol XR(Methandrostenolone)30t/25mg(Alpha Pharma)
Alphabol(Methandrostenolone)50t/10mg(Alpha Pharma)
Alphabolin(Methenolone Enatate)3amp/1ml/100mg/ml(Alpha Pharma)
Anabol Tablet(Methandrostenolone)1000tabs/5mg (British Dispensary Thailand)
Anadrol(Oxymetholone)100t/50mg (Lipthai)
Anadroxyl /Oxymetholone 50mg 50 tabs/ - Kalpa Pharmaceutical
Anapolon-50(Oxymetholone)20t/50mg(Abdi Ibrachim Turkey)
Anavar(Oxandrolone)100t/10mg(Lipthai)
Anavar(Oxandrolone)30t/10mg(Generics Pharm)
Anavarex(Oxandrolone)30tabs/5mg(Scantel Pharma Poland)
Androne 250(Testosterone Enanthate)10 x 1 ml/250mg(Caspian Tamin Pharmaceuticals Iran)
Androx 400 ( Testosterone Blend 400mg/ml x 10 Amps) Thaiger Pharma
Aquatest(Testosterone suspension)5 x 1ml/100mg (Balkan Pharmaceuticals)
Boldaxyl 300 /Boldenone Undecylenate 300mg/1ml 10 ml/ - Kalpa Pharmaceuiticals
Boldebolin(Boldenone undecyclenate) 250mg/ml(Alpha Pharma)
Boldenon(Boldenone undecyclenate)10ml/1000mg (Lipthai)
Boldenox(Boldenone undecyclenate)10ml/2000mg(Flor Medico)
Boldex U250 Swiss Pharm - Boldenone Undecylenate 10ml 250mg/1ml
C-Ject 250 (Testosterone Cypionate 250mg/ml x10 ampoules) Thaiger Pharma
CUTAXYL 150 /Drostanolone Propionate; Testosterone Propionate and Trenbolone Acetate/ 10ml - Kalpa Pharmaceuticals
D-Anabol 10(Methandrostenolone)100 tablets/10mg (Optimum Pharma Turkey)
Danabol DS(Methandrostenolone)500tabs/10mg(Body Research Thailand)
DEBOLON 10 | Methandienone 10 MG by Thaiger Pharma Group
Deca durabolin(Deca durabolin)10 x 1 ml/25mg/ml (Iran Hormon)
Deca durabolin(Generics Pharm)
Deca durabolin(Nandrolone Decanoate) 1ml/50mg(Organon Greece)
Deca durabolin(Nandrolone Decanoate) 2ml/200mg(Generics Pharm)
Deca durabolin(Nandrolone Decanoate)5 x 2ml/200mg(Organon Greece)
Decabol (Nandrolone Decanoate 1 ml 200 mg 10 ampoules) - NasPharma
Decabolon 100(Nandrolone Phenylpropionate) 100mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Decabolon 400(Nandrolone Decanoate 100 mg/ml Nandrolone Cypionate 100 mg/ml,Nandrolone Isocaproate 100 mg/ml,Nandrolone Undecanoate 100 mg/ml)400mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Decanox(Nandrolone decanoate)10ml/2500mg(Flor Medico)
Decatest 350(Nandrolone Decanoate 150mg/ml, Testosterone Enanthate 200mg/ml) 350mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
DEXADUR 350 (NANDROLONE MIX 350MG/ML) 10 AMPS THAIGER PHARMA DECA
Dianabol(Methandrostenolone)100t/10mg(Lipthai)
Dianabolic(Metandienone enantate)50mg/ml, 10ml(GEneral European Pharmaceuticals)
Dianoxyl 10 /Methandienone 10mg 100 tabs/ - Kalpa Pharmaceutical
Drostanolone Enanthate 10ml vial, 200mg/ml (Swiss Pharm)
Drostanolone(Drostanolone)100tabs/25mg (Biotech)
Duradexx 250 (Nandrolone Decaonate 250mg/ml x 10 amps) Thaiger Pharma
Duranox(Nandrolone phenylpropionate) 10ml/1000mg(Flor Medico)
Ecdysterone - VermoHerb 90 tabs. 250 mg
Equibolon 200(Boldenone Undecylenate) 200 mg/ml ,10 ml Glass Vials(Optimum Pharma Turkey)
Equibolon 400(Boldenone Undecylenate 100 mg/ml, Boldenone Cypionate 100 mg/ml, Boldenone Isocaproate 100 mg/ml, Boldenone Decanoate 100 mg/ml)400 mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Equitest 350(Boldenone Undecylenate 150 mg/ml +Testosterone Enanthate 200mg/ml)350 mg/ml,10 ml Glass Vials (Optimum Pharma Turkey)
Finarex Depot (Trenbolone Enanthate) 200mg/ml 10 ampoules Thaiger Pharma
FINEXAL-100 - THAIGER-PHARMA - 10 AMPS x 100mg/1ml
Floyd
Halotestin(Fluoxymesterone)50t/5mg(Hubei Huangshi Nanshang)
Haloxyl /Halotestin 10mg - 50 tabs/ - Kalpa Pharmaceutical
Indujekt-250 10amp/250mg/ml(Testosterone Propionate 30 mg/ml,Testosterone Phenylpropionate 60 mg/ml,Testosterone Isocaproate 60mg/ml,Testosterone Decanoate)10amp/1ml/250mg/ml(Alpha Pharma)
Kynoselen(Magnesium L-bi-aspartate,Potassium DL-aspartate,Selenium)100ml(Vetoquinol France)
Mastaplex 200(Axio Labs)
Mastebolin(Drostanolone propionate) 10amp/100mg/ml(Alpha Pharma)
Masteranox(Drostanolone di-propionate) 10ml/1000mg(Flor Medico)
Masterelon 100(Drostanolone Propionate) 100mg/ml, 10 ml Glass Vials(Optimum Pharma Turkey)
Masterelon 200(Drostanolone Enanthate) 200mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Masterolic(Drostanolone Propionate) 100mg/ml , 10 ml(GEneral European Pharmaceuticals)
Masteron(Drostanolone di-propionate) 2ml/200mg(Generics Pharm)
Mastoral(Methyl Drostanolone)(Superdrol) 50t/10mg(Alpha Pharma)
Megabol 200(Trenbolone Enanthate 100mg/ml + Stanozolol Cypionate 100mg/ml)200mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Megabol 225(Stanozolol Cypionate 100 mg/ml, Drostanolone Enanthate) 125mg/ml 225mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Megabol 250(Boldenone Undecylenate 100mg/ml, Drostanolone Enanthate 100mg/ml,1-Testosterone Cypionate/Dihydroboldenone 50mg/ml)250mg/ml,10 ml Glass Vials (Optimum Pharma Turkey)
Megabol 275(Trenbolone Enanthate 100mg/ml, Drostanolone Enanthate 100mg/ml,Stanozolol Cypionate 75mg/ml)275mg/ml,10 ml Glass Vials (Optimum Pharma Turkey)
Megabol 300(Trenbolone Enanthate 100mg/ml, Drostanolone Enanthate 100mg/ml,Testosterone Enanthate 100mg/ml)200mg/ml, 10 ml Glass Vials (Optimum Pharma Turkey)
Metanabol-10mg Methandienone 50 tabs - NasPharma
Metandienone(Methandrostenolone)100tabs/5mg(Akrihin Russia)
Metesto(Methyltestosterone)100tabs/25m(Lipthai)
Methandienone(Methandrostenolone)100t/10mg(Estopharma)
Methandienone(Methandrostenolone)100tabs/10mg (Biotech)
Methandiex(Methandrostenolone)30tabs/5mg(Scantel Pharma Poland)
Methenolone(Methenolone acetate)50tabs/10mg (Biotech)
Methyltestosterone(Methyltestosterone)100tabs/10mg(Biotech)
Nandro(Nandrolone Propionate)100mg/ml(Alpha Pharma)
Nandrobol(Nandrolone Decanoate)10ml/200mg/ml (Lipthai)
Nandrobolin-250(Nandrolone Decanoate) 250mg/ml (Alpha Pharma)
Nandrolona-D(Nandrolone Decanoate)5 x 1ml/200mg (Balkan Pharmaceuticals)
Nandrolone Decanoate 10ml vial, 250mg/ml (Swiss Pharm)
NandroRapid(Nandrolone Phenylpropionate) 100mg/ml(Alpha Pharma)
Nandroxyl 250 /Nandrolone Decanoate 250mg/ml 10ml/ - Kalpa Pharmaceuticals
Naposim(Methandrostenolone)20tabs/5mg(Terapia Romania/Ranbaxy)
Nebido(Testosterone undecanoate) 4ml/1000mg(Bayer Schering)
Norma Hellas(Nandrolone Decanoate)2 ml 100mg/ml (Norma Greece)
Omnadren(Testosterone Propionate 30 mg/ml,Testosterone Phenylpropionate 60 mg/ml,Testosterone Isocaproate 60mg/ml,Testosterone Decanoate)5 x 1ml/250mg(Jelfa Poland)
Oxanabol(Oxandrolone)50t/10mg(Alpha Pharma)
Oxandrolone 10 (Anavar) 100 tablets/10mg(Optimum Pharma Turkey)
Oxandrolone(Oxandrolon)30 tabs/2.5 mg(SPA Italy)
Oxandrolone(Oxandrolone)100t/10mg(Estopharma)
Oxandrolone(Oxandrolone)100tabs/10mg (Biotech)
Oxandroxyl 100 Tabs - Kalpa Pharmaceutical
Oxydrolone (Oxymetholone)50t/50mg(Alpha Pharma)
Oxymetholic(Oxymetholone)96 tabs - 2 blisters per 48 tabs/50mg(GEneral European Pharmaceuticals)
Oxymetholone IH 50(Anapolon)100t/50mg(Iran Hormon)
Oxymetholone(Oxymetholone)100tabs/25mg (Biotech)
Parabolan NEO(Trenbolone Hexahydrobenzylcarbonate)2ml/100mg(Generics Pharm)
Parabolan(Trenbolone Acetate)50t/10mg(Hubei Huangshi Nanshang)
Parabolan(Trenbolone Base)2ml/100mg(Generics Pharm)
Parabolan(Trenbolone Hexahydrobenzylcarbonate) 1,5 ml/76mg(Negma France)
Parabolan(Trenbolone Hexahydrobenzylcarbonate) 5 x 1ml/76mg(Balkan Pharmaceuticals)
Parabolin(Trenbolone Hexahydrobenzylcarbonate)5amp/76.5mg/1.5ml(Alpha Pharma)
PHENDUREN-275 - THAIGER-PHARMA - 10 AMPS ( 200mg/ml Nandrolone Decanoate, 75mg/ml Nandrolone Phenylpropionate)
Primanox(Methenolone enanthate)10ml/1000mg(Flor Medico)
Primobol(Methenolone Enanthate)5 x 1ml/100mg (Balkan Pharmaceuticals)
Primobolan TT(Methenolone Acetate) 30t/10mg(Generics Pharm)
Primobolane(Methenolone enanthate) 1ml/100mg(Bayer Schering Turkey)
Primobolon 100(Methenolone Enanthate) 100mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Primobolon 75(Methenolone Acetate 75mg/ml,10 ml Glass Vials)(Optimum Pharma Turkey)
Primoplex 100(Axio Labs)
PRIMOPRIM-100, 10 AMPS/1ML/100mg, THAIGER-PHARMA METENOLONE ENANTHATE
Primoxyl 100 /Methenolone Enanthate 100mg/ml/ - Kalpa Pharmaceuticals
PRONORM 100, 10 AMPS/1ML, THAIGER PHARMA INGREDIENT: TESTOSTERONE PROPIONATE PACKAGE: 10 AMP (100MG / AMP)
Provibol(Mesterolone)50t/25mg(Alpha Pharma)
Proviron(Mesterolone)20tabs/25mg(Bayer Greece)
Proviron(Mesterolone)30t/25mg(Hubei Huangshi Nanshang)
REMASTRIL100MG, 10 AMPS/1ML, THAIGER-PHARMA DROSTANOLONE PROPIONATE 10ML (100MG / 1ML)
Retabolil(Nandrolone Decanoate) 1 ml/50mg (Gedeon Richter Hungary)
RETOSTYL-250, 10 AMPS, 1ML, THAIGER-PHARMA TESTOSTERONE ENANTHATE 10 AMP (250MG / AMP)
Rexobol 10(Stanozolol)50t/10mg(Alpha Pharma)
Rexobol 50(Stanozolol)50t/50mg(Alpha Pharma)
Rexogin(Stanozolol suspension)10amp/50mg/ml(Alpha Pharma)
Stananox(Stanozolol suspension)10ml/500mg(Flor Medico)
Stanazolol(Stanozolol suspension)10ml/500mg (Lipthai)
Stanex 100 - Stanozolol 10ml vial, 100mg/ml (Swiss Pharm)
Stanolic(Stanozolol)96 tabs - 2 blisters per 48 tabs/10mg(GEneral European Pharmaceuticals)
Stanolon 10 (Stanozolol) 100 tablets/10mg(Optimum Pharma Turkey)
Stanolon 50(Stanozolol Aqua Suspension) 50mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Stanoxyl 50 /50mg 20 tabs/ - Kalpa Pharmaceutical
Stanozolol Aqua Supension 50mg/1ml Pharm-Tec
Stanozolol(Stanozolol)100 tab/10 mg(Lipthai)
Stanozolol(Stanozolol)100t/10mg(Estopharma)
Stanozolol(Stanozolol)100tabs/10mg(Biotech)
STORMBEAR 10 | Stanozolol 10 MG by Thaiger Pharma Group.
Stromba (Stanozolol 10 ampules 1 ml/50mg) - NasPharma
Stromba (Stanzolol 10mg) 50 Tablets - NaPharma
Stromba(Stanozolol)30t/10mg(Generics Pharm)
Strombaject Aqua(Stanozolol suspension) 5 x 1ml/mg(Balkan Pharmaceuticals)
SU-250, 10 AMPS / 1ML, THAIGER-PHARMA INGREDIENT: TESTOSTERONE MIX PACKAGE: 10 AMP (250MG / AMP)
SU-350, 10 AMPS/1ML, THAIGER-PHARMA INGREDIENT: TESTOSTERONE MIX PACKAGE: 10 AMP (350MG/1ML)
Sustamed(Testosterone Propionate 30 mg/ml,Testosterone Phenylpropionate 60 mg/ml,Testosterone Isocaproate 60mg/ml,Testosterone Decanoate)5 x 1ml/250mg (Balkan Pharmaceuticals)
Sustanon(Testosterone Propionate 30 mg/ml,Testosterone Phenylpropionate 60 mg/ml,Testosterone Isocaproate 60mg/ml,Testosterone Decanoate)100mg/ml)1x1ml/250mg (Organon Turkey)
Sustanon(Testosterone Propionate 30 mg/ml,Testosterone Phenylpropionate 60 mg/ml,Testosterone Isocaproate 60mg/ml,Testosterone Decanoate)3 x 1ml/250mg (Organon Pakistan)
Susteron (Sustanon 250) 250mg/1ml/10 ampoules - NasPharma
Sustex M250 - Testosterone Mix 10ml vial, 250mg/ml (Swiss Pharm)
Sustаbolon 250(Sustanon - Testosterone Propionate 30 mg/ml,Testosterone Phenylpropionate 60 mg/ml,Testosterone Isocaproate 60mg/ml,Testosterone Decanoate 100mg/ml)250mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Syntheselen(Magnesium Aspartate, Potassium Aspartate, Heptaminol HCL, Adenosine Triphosphate (ATP), Uridine Triphosphate, Sodium Selenite, Cyanacobalamin(B12)100ml (Synthetek USA)
Testanox C(Testosterone cypionate) 10ml/2000mg(Flor Medico)
Testanox E(Testosterone enanthate) 10ml/3000mg(Flor Medico)
Testanox P (Testosterone propionate) 10ml (Flor Medico) 1ml/100mg
Testanox S(Testosterone suspension) 10ml/1000mg(Flor Medico)
TestaPlex E 250(Axio Labs)
Testex C250 - Testosterone Cypionate 10ml vial, 250mg/ml (Swiss Pharm)
Testex E250 - Testosterone Enanthate 10ml vial, 250mg/ml (Swiss Pharm)
Testex Elmu Prolongatum (Testosterone cypionate)1ml/250mg(Altana Pharma, S.A. Spain)
TESTEX P100 - Testosterone Propionate 10ml vial, 100 mg/ml (Swiss Pharm)
Testo C(Testosterone cypionate)10ml/2000mg (Lipthai)
Testo E(Testosterone enanthate)10ml/2500mg (Lipthai)
Testo gel(Testosterone) 30pac/50mg(Bayer Greece)
Testo Mix(Testosterone Propionate 30 mg/ml,Testosterone Phenylpropionate 60 mg/ml,Testosterone Isocaproate 60mg/ml,Testosterone Decanoate)10ml/2500mg (Lipthai)
Testobolin(Testosterone Enanthate) 250mg/ml(Alpha Pharma)
Testolin (Testosterone Propionate 100mg / 1 ml 10 ampoules) - NasPharma
Testomax 75(1-Testosterone Cypionate /Dihydroboldenone)75m/ml,10 ml Glass Vials (Optimum Pharma Turkey)
TestoRapid(Testosterone Propionate) 100mg/ml(Alpha Pharma)
Testosteron Depo(Testosterone Enanthate) 10 x 1 ml/250mg (Aburaihan Iran)
Testosteron Depo(Testosterone Enanthate)5 x 1ml/250mg(Galenika Sarbia)
Testosterona-C(Testosterone cypionate)5 x 1ml/200mg(Balkan Pharmaceuticals)
Testosterone Propionate(Testosterone Propionate)5 x 1ml/50mg(Farmak Ukraina)
Testosterone Undecanoate(Testosteron Undecanoate)100t/20mg(Biotech)
Testostosteron Aqua Suspenension(Testosterone suspension)2ml/200mg(Generics Pharm)
Testostosterone Propionate(Testosterone Propionate)2ml/200mg(Generics Pharm)
Testoviron Depot(Testosterone Enanthate) 1ml/250mg(Bayer Greece)
Testаbolon 100(Testosterone Propionate) 100mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Testаbolon 200(Testosterone Cypionate) 200mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Testаbolon 250(Testosterone Enanthate) 250mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Testаbolon 400(Testosterone Enathate 100 mg/ml, Testosterone Cypionate 100 mg/ml,Testosterone Isocaproate 100 mg/ml,Testosterone Decanoate 100 mg/ml)400mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Testаbolon 75(Testosterone Propionate)75mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Trenabol (10 ampoules 200 mg) - NasPharma
Trenacet(Trenbolon acetate)100mg/ml,10ml (GEneral European Pharmaceuticals)
Trenanox A(Trenbolone acetate)10ml/750mg(Flor Medico)
Trenanox E(Trenbolone enanthate) 10ml/2000mg(Flor Medico)
Trenaplex A 100(Axio Labs)
Trenbol(Trenbolone acetate)10ml/760mg(Lipthai)
Trenbolin (10 ampoules 100mg) - NasPharma
Trenbolone 100(Trenbolone 6HBC)100mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Trenbolone 150(Trenbolone Acetate 50mg/ml, Trenbolone 6HBC 50mg/ml,Trenbolone Enathate 50mg/ml)150mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Trenbolone 200(Trenbolone Enathate) 200mg/ml,10 ml Glass Vials Optimum Pharma Turkey)
Trenbolone 75(Trenbolone Acetate)75mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Trenbolone Acetate(Trenbolone Acetate)50t/25mg (Biotech)
Trenboxyl Acetate 100 /Trenbolone Acetate/ - Kalpa Pharmaceuiticals
Trenex A100 - Trenbolone Acetate 10ml vial, 100mg/ml (Swiss Pharm)
Trenex E200 - Trenbolone Enanthate 10ml vial, 200mg/ml (Swiss Pharm)
Turanabol(4-Chlorodehydromethyltestosterone) 60t/10mg(Balkan Pharmaceuticals)
Turanaxyl /Turinabol 10mg 100 tabs/ - Kalpha Pharmaceuticals
Turinabol 10(4-chlorodehydromethyltestosterone) 100 tablets/10mg(Optimum Pharma Turkey)
Ultrabol 150(Trenbolone Acetate 50mg/ml, Drostanolone Propionate 50mg/ml,Testosterone Propionate 50mg/ml)150mg/ml,10 ml Glass Vials (Optimum Pharma Turkey)
Ultrabol 175(Trenbolone Acetate 75mg/ml, Drostanolone Propionate 100mg/ml)175mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Ultrabol 200(Trenbolone Acetate 100mg/ml, Testosterone Acetate 100mg/ml)200mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Ultrabol 225(Trenbolone Acetate 75 mg/ml, Testosterone Acetate 75mg/ml,Methelonone Acetate 75mg/ml)200mg/ml,10 ml Glass Vials (Optimum Pharma Turkey)
Ultrabol 250(Trenbolone Enanthate 125mg/ml, Drostanolone Enanthate 125mg/ml) 200mg/ml,10 ml Glass Vials(Optimum Pharma Turkey)
Ultrabol 275(Optimum Pharma)
Ultrabol 300(Boldenone Undecylenate 100mg/ml, Trenbolone Enanthate 100mg/ml, Testosterone Enanthate 100mg/ml)300mg/ml, 10 ml Glass Vials(Optimum Pharma Turkey)
Undestor Testocaps(Testosterone undecanoate) 30 capsules/40mg(Organon Turkey)
VEBOLDEX 400, 10 AMPS - 1ML, THAIGER PHARMA INGREDIENT: BOLDENONE UNDECYLENATE PACKAGE: 10 AMPS (400MG / AMP)
VEBOLDEX-250, 10 AMPS - 1ML, THAIGER-PHARMA INGREDIENT: BOLDENONE UNDECYLENATE PACKAGE: 10 AMPS (250MG / AMP)
VENAJECT 100, 10 AMPS - 1ML, THAIGER PHARMA INGREDIENT: STANOZOLOL PACKAGE: 10 AMPS (100MG / AMP)
Winstrol TT(Stanozolol)20t/2mg(Zambon Spain)
Winstrol(Stanozolol suspension) 3x1,5ml/50mg (Desma Group Spain)
Winstrol(Stanozolol)20t/2mg(Desma Group Spain)
XANDROL 10 | Oxandrolone 10 MG by Thaiger Pharma Group
XYTHOZEN 50 | Oxymetholone 50 MG by Thaiger Pharma Group.
Рибоксин(Inosine)50tabs/200mg(Киевский Витаминньiй завод Украйна)
     ALL

Price: $ 120.00 
 
Quantity:




Syntheselen(Magnesium Aspartate, Potassium Aspartate, Heptaminol HCL, Adenosine Triphosphate (ATP), Uridine Triphosphate, Sodium Selenite, Cyanacobalamin(B12)100ml (Synthetek USA)

Item 12672

Syntheselen – Metabolic Stimulator

INGREDIENTS: Magnesium Aspartate, Potassium Aspartate, Heptaminol HCL, Adenosine Triphosphate (ATP), Uridine Triphosphate, Sodium Selenite, Cyanacobalamin (B12)

100ml bottle.

Usage: 1ml per 55lbs (25kg) of bodyweight per day

You heard about Kynoselen… this is the more potent, safer human version!

Syntheselen™ is an effective aid in the body’s fat loss, muscle growth and cardiovascular system improvements. It achieves this by stimulating the metabolic oxidation and energy transformation processes.

Syntheselen™ is very effective at helping athletes become leaner, by reducing their body fat levels. It also helps build lean muscle mass as well as enhancing energy levels by increasing the athlete’s cardiovascular endurance.

Syntheselen™ is an Adenosine Triphosphate (ATP) and Uridine Triphosphate based sterile preparation manufactured by a pharmaceutical company in accordance with the highest level of manufacturing practices.

The focus of this article will center on energy (ATP) and its relationship to protein synthesis. By necessity we will keep the specifics of operations at molecular level to a minimum.

Protein Synthesis during resistance exercise

What has long been known?

It has been established for some time now that both muscle protein synthesis 1-4 and muscle protein degradation are stimulated by resistance exercise2-4.

Traditionally the overall net effect (synthesis - degradation = + or -) has been understood to depend on what happens in the post exercise environment.

In that environment protein degradation is brought to an end if carbohydrates are ingested following resistance exercise while net protein synthesis (i.e. protein synthesis exceeds protein degradation) is achieved only if both carbohydrates and protein are ingested following the resistance exercise session 5-10.

These concepts are so well established as evidenced by the numerous references cited herein that it is barely worth mentioning.

 

What is interesting however and worth spending some time on is what happens to protein synthesis during resistance exercise.

Achieving that understanding allows us to move into a new area and explore the concept of energy balance and protein synthesis and thanks in part to recent research examine the specific relationship between ATP concentration and protein synthesis.

Where this article intends to go

Energy state in general and ATP concentration specifically is vitally important in the fueling of muscular movement and contraction. ATP is often discussed in the context of sports as a means to reduce fatigue.

Yet protein synthesis is an extremely energy demanding process requiring the utilization of ATP. The availability of energy, specifically ATP is a limiting factor in the synthesis of muscle protein.

The extent to which protein synthesis will occur is dependant on several factors not the least of which is the availability of ATP. When we engage in resistance exercise we are using energy that will not be available to the components of the system which drive muscle protein synthesis and subsequently tissue accrual.

Is it possible to engage in resistance exercise and have net protein synthesis occur at the same time?

What has recently been understood?

In contrast to protein metabolism in the post exercise environment very little was known about the effect of nutrition on muscle protein synthesis during exercise until the year 2008. Up until that time only two studies had been done and they weren’t even done on muscle. Rather they focused on whole body protein turnover. They reported an increase in whole body protein balance after protein and carbohydrate ingestion during exercise but neither one examined what was happening at the muscular level during exercise11, 12.

The Tipton study 12 did go a step further and examined muscle protein synthesis post exercise. This led them to suggest that protein ingestion before, rather then after exercise might better increase net muscle protein accretion during post exercise recovery.

The effect of protein and carbohydrate ingestion on muscle protein synthesis during exercise was eventually established in 2008 when Beelen, et al published Protein coingestion stimulates muscle protein synthesis during resistance-type exercise, Am J Physiol Endocrinol Metab 295: E70–E77, 2008.

In that study they proved that even in the fed state, additional coingestion of protein and carbohydrates before and during resistance exercise improved whole body protein balance and stimulated muscle protein synthesis during exercise.

They didn’t just find a little benefit, rather they found that ingestion of protein and carbohydrates substantially increased muscle protein synthesis rates. This led them to conclude:

“Consequently, our findings suggest that protein coingestion during exercise could represent an effective dietary strategy to further augment muscle protein accretion by creating a larger time frame for muscle protein synthesis to be elevated.”

Although the authors did not specifically frame their results in terms of energy we can do that. Previous studies that demonstrated that resistance exercise stimulated both muscle protein synthesis and breakdown rates found that in the absence of subsequent food intake net protein balance remained negative 1,2,4.

Previous studies carried out their investigations using participants who were subjected to an overnight fast. Dreyer et al reported lower muscle protein synthesis rates during resistance exercise compared with rest and post exercise recovery 13. This strongly contrasts with the results from the aforementioned Beelen, et al study leading the authors to underscore the difference in methodology:

“The apparent discrepancy might be explained by the fact that subjects in the present study were investigated in the fed state and ingested carbohydrate with or without additional protein during exercise.”

Since the Beelen, et al study was published several studies have been published with what appears to be mixed results involving various protocols. The elderly for example have a difficult time engaging protein synthesis no matter what the protocol. A good example of a study that appears to contrast the Beelen, et al study but actually doesn’t when the methodology is examined is Essential amino acid and carbohydrate ingestion before resistance exercise does not enhance postexercise muscle protein synthesis, Satoshi Fujita, J Appl Physiol 106: 1730-1739, 2009. In that study they administered essential amino acids and carbohydrates one hour before exercise and found an increase in muscle protein synthesis which returned to base during exercise.

This study underscores the concept of energy inputs driving both muscle contractions and energy intensive protein synthesis and highlights the need to sufficiently meet that energy requirement throughout the exercise period.

References:

1 – Biolo G, Maggi SP, Williams BD, Tipton KD, Wolfe RR, Increased rates of muscle protein turnover and amino acid transport after resistance exercise in humans, Am J Physiol Endocrinol Metab 268: E514–E520, 1995
2 – Phillips SM, Tipton KD, Aarsland A, Wolf SE, Wolfe RR,
Mixed muscle protein synthesis and breakdown after resistance exercise in humans, Am J Physiol Endocrinol Metab 273: E99–E107, 1997
3 – Sheffield-Moore M, Yeckel CW, Volpi E, Wolf SE, Morio B, Chinkes DL, Paddon-Jones D, Wolfe RR ,
Postexercise protein metabolism in older and younger men following moderate-intensity aerobic exercise, Am J Physiol Endocrinol Metab 287: E513–E522, 2004
4 – Tipton KD, Ferrando AA, Williams BD, Wolfe RR,
Muscle protein metabolism in female swimmers after a combination of resistance and endurance exercise, J Appl Physiol 81: 2034–2038, 1996
5 – Biolo G, Tipton KD, Klein S, Wolfe RR,
An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein, Am J Physiol Endocrinol Metab 273: E122–E129, 1997
6 – Borsheim E, Tipton KD,Wolf SE,Wolfe RR,
Essential amino acids and muscle protein recovery from resistance exercise, Am J Physiol Endocrinol Metab 283: E648–E657, 2002
7 – Koopman R,Wagenmakers AJ,Manders RJ, Zorenc AH, Senden JM, Gorselink M, Keizer HA, van Loon LJ,
Combined ingestion of protein and free leucine with carbohydrate increases postexercise muscle protein synthesis in vivo in male subjects, Am J Physiol Endocrinol Metab 288: E645–E653, 2005
8 – Miller SL, Tipton KD, Chinkes DL, Wolf SE, Wolfe RR ,
Independent and combined effects of amino acids and glucose after resistance exercise, Med Sci Sports Exerc 35: 449–455, 2003
9 – Rasmussen BB, Tipton KD, Miller SL, Wolf SE, Wolfe RR,
An oral essential amino acid-carbohydrate supplement enhances muscle protein anabolism after resistance exercise, J Appl Physiol 88: 386–392, 2000
10 – Tipton KD, Ferrando AA, Phillips SM, Doyle D Jr, Wolfe RR ,
Postexercise net protein synthesis in human muscle from orally administered amino acids, Am J Physiol Endocrinol Metab 276: E628–E634, 1999
11 – Koopman R, Pannemans DL, Jeukendrup AE, Gijsen AP, Senden JM, Halliday D, Saris WH, van Loon LJ, Wagenmakers AJ,
Combined ingestion of protein and carbohydrate improves protein balance during ultra-endurance exercise, Am J Physiol Endocrinol Metab 287: E712– E720, 2004
12 – Tipton KD, Rasmussen BB, Miller SL, Wolf SE, Owens-Stovall SK, Petrini BE, Wolfe RR,
Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise, Am J Physiol Endocrinol Metab 281: E197–E206, 2001
13 – Dreyer HC, Fujita S, Cadenas JG, Chinkes DL, Volpi E, Rasmussen BB,
Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle, J Physiol 576: 613–624, 2006

ATP = Energy

The most important form of storage for chemical energy in all cells is adenosine triphosphate (ATP). Energy is stored in the chemical bonds within molecules. When bonds are formed potential energy is created and when those bonds are broken energy is released.

ATP synthesis in animals requires the absorption of energy from a catabolic conversion of adenosine diphosphate (ADP) and phosphate (Pi) to ATP. ATP synthesis involves the making of new bonds and results in stored potential energy.

Cleavage of ATP by breaking these bonds back into ADP and phosphate releases energy. This process is known as ATP hydrolysis.

A healthy cell must maintain a high ratio of ATP to ADP (of the order of 10:1) so that it possesses potential energy. If the ratio of ATP and ADP becomes equal (1:1) a stable equilibrium will result with no further net hydrolysis of ATP, which means no more energy release.

Almost all energy-requiring processes in the cell are driven, either directly or indirectly, by hydrolysis of one or other of the bonds in ATP, yielding either ADP or adenosine monophosphate (AMP).

Healthy cells maintain the reactants and products of these two reactions many orders of magnitude away from their equilibrium ratios. This is why ATP hydrolysis is able to perform useful work when coupled to processes requiring an input of energy.

Think of ATP in a cell as chemicals in an electrical battery. The “battery” of the cell is charged up by catabolism which converts ADP and Pi to ATP. The cell holds potential energy and the ability to make things happen such as activating anabolic pathways and facilitating movement and transport processes.

Almost all cellular processes require ATP breakdown and therefore tend to discharge the “battery”. For the reason that it is critical to the cell to maintain the appropriate ratios of ATP:ADP and ATP:AMP, complex and redundant mechanisms have evolved to regulate these ratios.

References:

Atlas of Biochemistry Second edition, Jan Koolman, Thieme Stuttgart New York 2005
AMP-activated protein kinase: the energy charge hypothesis revisited, D. Grahame Hardie, BioEssays 23:1112-1119, 2001

Fuel Selection during exercise

ATP directly powers myosin, the muscle protein immediately responsible for converting chemical energy into movement. However, the amount of ATP in muscle is small. Therefore the power output and in turn, the force generated by muscular contraction depend on the rate of ATP production from other fuels. Creatine phosphate (phosphocreatine) can swiftly transfer its high-potential phosphoryl group to ADP to generate ATP. However, the amount of creatine phosphate, like that of ATP itself, is limited. Creatine phosphate and stored ATP are able to power intense muscle contraction for 5 to 6 seconds.

A set of weight lifting repetitions will be powered by stored ATP, creatine phosphate’s creation of ATP, and a third process known as the anaerobic glycolysis of muscle glycogen into lactate which generates more ATP.

This third process, the conversion of muscle glycogen into lactate, can generate a good deal more ATP, but the rate is slower than that of phosphoryl-group transfer from creatine phosphate. During the first 10 seconds of a set, the ATP level in muscle drops from 5.2 to 3.7 mM, and that of creatine phosphate decreases from 9.1 to 2.6 mM. The third process of anaerobic glycolysis results in the elevation of the blood-lactate level from 1.6 to 8.3 mM. The release of hydrogen ions (H+) from the intensely active muscle lowers the blood pH from 7.42 to 7.24.

The power generated during repetitions slows as, creatine phosphate is consumed within a few seconds and the lactate produced brings about acidosis. Thus, alternative fuel processes are needed for continued movement & force generation beyond the maximum time frame of 2 minutes that these fuel processes will be able to power.

The next (or 4th) fuel process tapped into is the oxidation of muscle glycogen to CO2 which substantially increases the energy yield, but this aerobic process is a lot slower than drawing directly on ATP stores and creation of ATP from creatine phosphate and anaerobic glycolysis.

In a long distance running event this slower fourth fuel process of aerobic respiration, or oxidative phosphorylation, becomes increasingly important. For instance, part of the ATP consumed in a 1000-meter run must because it lasts longer then 2 minutes come from oxidative phosphorylation.

Longer distances such as marathon running require further energy conversion methods which proceed to a fifth fuel process known as oxidation of liver glycogen to CO2 and a sixth fuel process requiring tapping into stored energy reserves in adipose tissue resulting in oxidation of adipose-tissue fatty acids to CO2.

References:

Hultman, E. and Harris, R. C., In Principles of Exercise Biochemistry, J. R. Poortmans (Ed.), Karger, 1988
Berg, Jeremy M. and Tymoczko, John L.,
Lubert Stryer, Biochemistry, Fifth Edition, W. H. Freeman 2002

In conclusion:

The significance of mismatching the quantity of energy required to perform high-intensity exercise results in fatigue, or the inability to generate and maintain the desired force output.

The significance of mismatching the quality of the energy required to perform high-intensity exercise does not reveal itself straight away.

For example, “too much carbohydrate utilization will allow maintenance of a high exercise intensity but will cause rapid glycogen depletion and fatigue. Too little carbohydrate utilization will spare precious glycogen reserves but, by forcing greater reliance of fatty acid oxidation, will constrain exercise to a relatively low intensity. Therefore, the body systems designed to sense, integrate, and deliver the appropriate energy to match demand, must be sensitive to the quality of the energy required as well as the quantity. Over the long-term (days/weeks/months), energy supply can be mismatched to demand with no acute loss of function, but with potent consequences for body composition and exercise.” – Sports Nutrition: Energy Metabolism and Exercise, Edited By Ira Wolinsky Judy A., Driskell, CRC Press 2008

Relationship between ATP concentration and protein synthesis

The amount of protein synthesis that takes place during and after exercise is dependent on several factors, including a complete complement of precursor amino acids, specific acetylating enzymes, tRNA, and adequate ATP levels.Di Pasquale, Mauro G., MD, Amino Acids and Proteins for the Athlete The Anabolic Edge Second Edition, CRC Press, 2008

Intense exercise and inadequate or ill-timed nutrition may result in inadequate ATP levels and rationing of ATP usage for protein synthesis unrelated to tissue accrual. Low energy states no matter how they are brought about result in suboptimal muscular protein synthesis.

The metabolic system for protein synthesis is the most energy demanding process. It has been shown, for example, that protein synthesis consumes approximately two-thirds of the total energy produced by rapidly growing cells 1. Each step requires the use of ATP. Adding just one amino acid to a growing polypeptide chain requires the energy derived from 4 ATP molecules.

The loading of an amino acid onto a tRNA is the single most energy demanding step of protein synthesis. The linking (loading) of an amino acid to its corresponding tRNA is catalyzed by an enzyme called aminoacyl-tRNA synthetase. The cleavage of ATP (as described previously) releases the energy necessary to drive this activation reaction. 2

For each amino acid there is usually one activating enzyme and at least one kind of tRNA. This linking (loading) process occurs for each amino acid that is added to the amino acid chain.

From this very basic description it is easy to understand the extent of energy consumption required in the process of linking 40 or more amino acids per second.

Protein synthesis described in the simplest terms involves:

  • getting the code from DNA;
  • providing a template or instructions for exactly which amino acids will go where when constructing the amino acid chain;
  • loading one of the twenty standard amino acids to a tRNA molecule specifically made for that amino acid;
  • moving each tRNA into place based on the template;
  • terminating the assembly and freeing the complete amino acid chain now called a peptide or protein

The entire assembly of individual amino acids as described above, into a polypeptide chain or protein takes place in the ribosomes. So to Dr. Mauro G. Di Pasquale’s list of necessary items: amino acids, specific acetylating enzymes, tRNA, and adequate ATP levels, we can add another; ribosomes.

 

All must be present in sufficient quantities to meet the demands of maximum protein synthesis.

During times of rapid growth ATP is maintained at a relatively constant level. However when energy is limited ATP concentrations become very low. It is during these times where the cell must make only proteins essential to its survival. In addition vital processes receive preferential treatment in receiving limited energy. For example, ATP dependent proteases are needed to breakdown intracellular proteins during starvation. This puts a stop on undesirable reactions and provides amino acids for new protein synthesis. This allows the cell to remodel itself in order to survive. During these periods ATP is rationed among energy dependent metabolic processes. This is accomplished by increasing ATP affinity (i.e. attraction) in crucial processes. This allows the cell to preferentially channel energy resources to only those protein synthesis events or metabolic processes it deems vital.3.

During periods of high growth the number of ribosomes per cell dramatically increases. Under slower growth rates, ribosome concentrations decrease. A 10-fold decrease has been observed in conditions where energy availability became limited 4. The other factors required for the translation process of protein synthesis are also down regulated 5.

There is a direct and measurable relationship between the quantity of ATP and the amount and type of protein synthesis that will occur. Higher, adequate levels precede the type of protein synthesis that leads to tissue accrual and anabolism (muscle protein synthesis). Lower, inadequate levels do not.

References:

Note – Many of the statements in the above section were drawn from discussion in the study noted below in reference 5.

1 – Neijssel, O. M., Teixeira de Mattos, M. J., and Tempest, D. W., Growth Yield and Energy Distribution. p. 1683-1692. In F.C. Neidhart et al. (eds.), Escherichia coli and Salmonella, Cellular and Molecular Biology, 2nd ed., American Society for Microbiology, Washington DC. 1996
2 – Berg, Jeremy, M. Tymoczko, John L.,
Lubert Stryer, Biochemistry, Fifth Edition, W. H. Freeman 2002
3 – Snoep, J. L., Bruggeman, F., Olivier, B. G., and Westerhoff, H. V.,
Towards building the silicon cell: a modular approach, Biosystems 83:             207-216 2006      
4 – Bremer, H., and Dennis, P. P.,
Modulation of chemical composition and other parameters of the cell by growth rate p. 1553-1569, In F.C. Neidhart et al. (eds.), Escherichia coli and Salmonella, Cellular and Molecular Biology, 2nd ed., American Society for Microbiology, Washington DC. 1996
5 – Jewett, Michael C.,
Continued protein synthesis at low [ATP] and [GTP] enables cell adaptation during energy limitation, J Bacteriol. 2009 Feb;191(3):1083-91

Exogenous ATP how does it affect the cell?

Biochemically, there are two ways of approaching the problem that fatigue poses to athletes. One hypothetical way is to increase the level of ATP in the tissues, either by exogenous administration of ATP, or by increasing endogenous production of the energy-rich compoundsDi Pasquale, Mauro G. (2008)

Amino acids will not be efficiently incorporated into protein without enough energy sources from other foods, first because of the energy consumed in heat loss during their metabolism. Second because incorporation of amino acids into peptides requires three high-energy phosphate bonds, thereby using 10 kcal/mol derived from hydrolysis of ATP. Any excess of dietary energy over basic needs thus improves the efficiency of dietary nitrogen utilization. -Di Pasquale, Mauro G. (2008)

There are three ways that ATP from outside the cell can effect what happens inside the cell.

  • Extracellular ATP can bind to “ATP-receptors” of which there are several subtypes. These receptors reside on the cellular membrane and open ion channels permitting passage of small ions and larger molecules.
  • Extracellular ATP can break down at the cellular membrane into its break down products (ADP, AMP, adenosine and inorganic phosphate) some of which pass into the cell by a specific transporter and are rephosphorated there into ATP.
  • Extracellular ATP can cross the membrane and be taken up into the cell. This claim is still controversial and the mechanism is not precisely known. There is sufficient evidence that this is so and some of that evidence will be discussed herein.

No matter which method or methods occur, extracellular ATP does effect what happens inside the cell in ways that can be positive for body building.

ATP-receptors

ATP is naturally present outside cells. Many cell types release ATP, and the mechanisms and physiological circumstances range from relatively well understood to quite controversial. ATP could also be supplied exogenously.

One of the ATP receptor subtypes (P2X) is heavily expressed in skeletal muscle1. It has been strongly suggested by the Urano et al study that this receptor may play a significant role in the proliferation and/or differentiation of skeletal muscle cells.

There is a relationship between growth factors and ATP that determines whether a cell dies or proliferates. It is only possible for us to get a general feel for this relationship and perhaps the following quotes will help.

“Growth factor receptors have evolved to regulate growth and proliferation in response to changes in the availability of growth factors. Growth factor receptors also have the ability to control cell survival, in addition to growth and proliferation. The ability of Growth factor receptors to control cell survival involves the regulation of mitochondrial homeostasis 2.”

“It is probable that direct alterations in cellular metabolism can alter cell survival. It has long been recognized that a decline in the concentration of ATP follows Growth factor withdrawal, and so it is logical that the addition of ATP would prevent cell death, and indeed the addition of exogenous ATP does inhibit cell death 3,4.”

Although not clearly understood, there appears to be a direct relationship between the concentration of ATP and growth factors that determine the extent to which growth and proliferation or even death occurs. What happens at the macro-level (whole body, what the mirror reveals) regarding energy status and body mass also occurs at the micro-level (cell, what the microscope reveals). In simple terms increased energy input leads to growth while decreased energy states do not. From our previous discussion we know that when the concentration ratio of ATP to ADP drops to a ratio of 1 to 1 the cell loses its ability to channel energy. The “battery” discharges.

So for example when we subsequently encounter a study where arrested heart tissue is revived and pulsatility resumed simply by adding exogenous ATP it should not be a mystery. Neither should it be a suprise that growth factor concentration maintains some dependence on ATP concentration, because in general it should just make sense.

Back to receptors

As can be seen from the following image the act of ATP binding to an ATP receptor (P2X7) has the effect of opening a channel permeable to small ions (cations) or a wider channel permeable to larger molecules (anions). It does so either by conformational change as demonstrated in illustration A or by opening a separate channel as shown in illustration B.

 

Example of ATP:ATP receptor complex in action

ATP receptors are located in many places such as the pituitary the activation of which can even affect the release of hormones. As an example the following study discovered a relationship between pituitary ATP receptors and the regulation of luteinizing hormone (LH). Luteinizing hormone is a hormone which stimulates Leydig cell production of testosterone.

In the study by Chen et al, it was determined that ATP receptors in the pituitary are capable of bringing about the release of luteinizing hormone from gonadotropes when activated by either ATP or a similar nucleotide uridine triphosphate (UTP). UTP is a nucleotide similar to ATP, but with an increased specificity.

Both ATP and UTP caused a 14-fold increase in the rate of luteinizing hormone release from superfused cells. They were able to affect this increase by mediating an intracellular Ca2+ inflow into the gonadotrope which apparently released all of the luteinizing hormone stores.

The authors go on to conclude “the superfusion data clearly demonstrate that gonadotropes are targets for extracellular nucleotides through a single class of ATP receptors characterized as the P2U subtype, activation of which can be an effective stimulator of LH release.5

It is interesting to note that Ca2+ inflow into hormone-releasing cells in the pituitary is a common release mechanism for various hormones. The hormone Ghrelin and Ghrelin-mimetics such as GHRP-6 operate on GH-releasing pituitary cells in a similar fashion through their own GHS-receptors.

References:

1 – Urano T, Nishimori H, Han H, Furuhata T, Kimura Y, Nakamura Y, and Tokino T., Cloning of P2XM, a novel human P2X receptor gene regulated by p53, Cancer Res 57: 3281-3287, 1997
2 – Raff, M.C.,
Social controls on cell survival and cell death, Nature 356, 397–400 (1992)
3 – Whetton A. D., Dexter T. M.,
Effect of haematopoietic cell growth factor on intracellular ATP levels, Nature 303, 629-631 (16 June 1983)
4 – Plas, D.R, and Thompson, C. B.,
Cell metabolism in the regulation of programmed cell death, TRENDS in Endocrinology & Metabolism Vol.13 No.2 March 2002
5 – Chen, Zhen-Ping,
Evidence for a role of pituitary ATP receptors in the regulation of pituitary function, Proc. Natl. Acad. Sci. USA Vol. 92, pp. 5219-5223, May 1995 Physiology

ATP Protein Synthesis

Exogenously administered ATP can increase protein synthesis particularly in low energy state conditions.

For example protein synthesis is severely depressed in brain tissue following episodes where there is a restriction in blood supply (ischemic episode). Restoration of protein synthesis is essential for neuron survival.

In the Paskitti et al 1 study they infused ATP and Magnesium chloride (which stabilizes ATP 2) after inducing restricted blood flow and demonstrated an improved protein synthesis which better preserved neurons.

It was an increase in normal protein synthesis that exogenous ATP administration was able to bring about. The trauma of restricted blood flow increased synthesis of heat shock and other stress-induced proteins, along with a severe decrease in the proteins needed to maintain cellular structure and function. Exogenously administered ATP made available ATP which appears to have crossed the cellular membrane and restored a depleted ATP level needed for healthy cellular function and increased overall protein synthesis.

The authors ascribed the benefit to ATP directly entering the cell rather then any mediation of ATP receptors or entry of breakdown products.

But even if only breakdown products enter the cell the result could be the same. Fedelesova et al 3 noted studies that revealed that administration of ATP into an animal heart had a positive effect on fatigued muscle. One study in particular revived an arrested heart tissue restoring normal pulsation. Another demonstrated that loss of glycogen and phosphocreatine could be mitigated by injection of ATP into the blood stream. While still another restored impaired cellular function and metabolism in the myocardium simply by supplying exogenous ATP. So Fedelesova et al undertook to determine if ATP and its breakdown products were able to enter myocardium cells.

They found that injected ATP was primarily split into ADP, AMP, adenosine and inorganic phosphate with some of these products entering the cell and being reconstituted into ATP. They allowed for the possibility of some ATP entering the cell. Their results prompted them to ask “to what extent does the widely accepted notion of the impermeability of the cell membrane to ATP require revision?”

References:

1 – Paskitti, M. and Reid, K.H., Use of an adenosine triphosphate-based ‘cocktail’ early in reperfusion substantially improves brain protein synthesis after global ischemia in rats, Neuroscience Letters 331 (2002) 147–150
2 – Chaudry, I.H., Clemens, M.G. and Baue, A.E.,
Alterations in cell function with ischemia and shock and their correction, Arch. Surg., 116 (1981) 1309–1317
3 – Fedelesova, M. Ph.D.,
Effect of Exogenous Adenosine Triphosphate on the Metabolic State of the Excised Hypothermic Dog Heart, Circulation Research, Vol. XXIV, May 1969

Does ATP cross the cell membrane?

The original notion that cell membranes are impermeable to ATP came from failing to recognize it as one of the exceptions to the general theory, established in the first have of the 20th century that cell membranes are impermeable to anions (negatively charged ions).

In the absence of evidence to the contrary the notion prevailed and continues to this day in part because it is very difficult to measure directly.

Many of the metabolic systems that use ATP are located in the cytoplasm of cells, while it is the mitochondria that synthesizes ATP during aerobic oxidative phosphorylation. There is no doubt that ATP is an energy supplier to various intracellular reactions and muscle contraction outside the mitochondria. Consequently ATP must cross intracellular membranes 2-4.

Boyd and Forrester showed that ATP was released from contracting skeletal muscle in vitro and then Forrester subsequently showed that ATP was released into the venous effluent from human forearm muscle during performance of isometric exercise 5,6.

These results were substantiated by Parkinson in 1973 7 who noted an increase in blood levels of ATP, ADP, and AMP occurring as long as five minutes after whole body exercise.

The results of these and other studies prompted Chaudry 1 to conclude “it is clear that active skeletal muscle, cardiac muscle, and brain tissue release significant concentrations of ATP into the extracellular space sufficient to profoundly affect local blood flow. A residual amount of ATP and other nucleotides may also reach the general circulation and indeed nucleotides have been detected in the human circulation as long as five minutes after whole body exercise.”

ATP Uptake by Tissue

If ATP crosses cellular membranes to leave the cell, does it also cross the membrane to enter the cell?

ATP uptake was first suggested and ignored in 1947 when externally added ATP induced contractions in muscle fibers 8. In 1970 it was definitively shown that exogenous ATP entered intact skeletal muscle cells in vitro. Evidence was provided that the labeled ATP present intracellularly was due to the transport of ATP itself from the incubation medium and not due to the formation of ATP from its breakdown products9.

These results were confirmed in a follow-up study demonstrating uptake of ATP by soleus muscle and the presence of the labeled ATP intact inside the cell 10.

In another study by Ziegelhoffer et al. 11 it was demonstrated that small amounts of exogenous ATP but not ADP or AMP increased the ATP and the total adenine nucleotides of the hypoxic myocardium. Williams et al. 12 were able to show that the addition of ATP but not ADP or adenosine to the medium caused an increase of ATP contents of the cultured myocardial cells. These studies therefore indicate that ATP itself but not its breakdown products increase intracellular ATP levels.

A study by Maxild 13 provided evidence for renal uptake of externally added ATP. In that study he concluded that ATP is taken up into the renal cells by the transport system of organic anions.

Several studies by Ayad and Hughes 14 lend support. They concluded that ATP enters the cells and acts as a substrate for adenylate cyclase.

Pant et al. 15 found that the same set of proteins were phosphorylated in the axoplasm [cytoplasm within the axon of a neuron] regardless of whether the ATP was applied intracellularly or extracellularly. “These results therefore indicate that ATP in the extracellular space is utilized by some ATP translocation mechanism in the process of intracellular phosphorylation. Measurements of the apparent influx of ATP across the axon membrane yielded results consistent with the view that ATP in the extracellular fluid could be transported into the axoplasm.”

In conclusion, it appears that ATP can cross the cell membrane.

References:

1 – Chaudry, I. H., Does ATP Cross the Cell Plasma Membrane?, The Yale Journal Of Biology And Medicine 55 (1982), 1-10
2 – Long, C,
The in vitro oxidation of pyruvic and ketobutric acids by ground preparations of pigeon brain: The effect of inorganic phosphate in adenine nucleotides, Biochem J 37:215-225, 1943
3 – Green HN, Stoner HB,
Biological actions of adenine nucleotides, London, HK Lewis and Cole, Ltd, 1950, pp 9-23
4 – Hajuda S, Gyorgya SA, Action of DOC and serum on frog heart, Am J Physiol 168:159-170, 1952
5 – Boyd I. A, Forrester T, The release of adenosine triphosphate from frog skeletal muscle in vitro, J Physiol (London) 199:115-135, 1968
6 – Forrester T, An estimation of adenosine triphosphate release into the venous effluent from exercising human forearm muscle, J Physiol (London) 224:611-628, 1972
7 – Parkinson PI, The effect of graduated exercise on the concentration of adenine nucleotides in plasma, J Physiol (London) 248:72-74P, 1973
8 – Buchthal F, Deutsch A, Knappies GG, Further investigations on the effects of adenosine triphos- phate and related phosphorus compounds on isolated striated muscle fibers, Acta Physiol Scand 11:325-334, 1946
9 – Chaudry IH, Gould MK, Evidence for the uptake of ATP by rat soleus muscle in vitro, Biochim Biophys Acta 196:320-326, 1970
10 – Chaudry IH, Baue AE, Further evidence for ATP uptake by rat tissues, Biochim Biophys Acta 628:336-342, 1980
11 – Ziegelhoffer A, Fedelesova M, Kostalansky S, Specific ATP action on metabolism of isolated heart. Influences of pH, divalent cation concentration and stability of complexes, Acta Biol Med Germ 28:893-900, 1972
12 – Williams D, Ribell D, Rovetto MJ, ATP induced increase in ATP content of cultured myocardial cells, Fed Proc 38:1389, 1979
13 – Maxild J, Effect of externally added ATP and related compounds on active transport of P-amino- hippurate and metabolism in cortical slices of the rabbit kidney, Arch Int Physiol Biochem 86:519-530, 1978
14 – Ayad SR, Hegges RJ, ATP enhances cyclic AMP accumulation by intact P 388 mouse lymphoma cells, Biochim Biophys Acta 630:193-201, 1980
15 – Pant HC, Terakawa S, Yoshioki T, et al, Evidence for utilization of extracellular gamma-32P ATP for phosphorylation of intracellular protein in the squid giant axon, Biochim Biophys Acta 582:107-114, 1979

In Summary

Maximum muscle protein synthesis is achieved only when energy state is sufficient to power vital cellular processes, power the force generation and movement requirements of exercise and power the components involved in assembling amino acid chains. ATP is the energy molecule that makes all of this possible.

Muscle protein synthesis and resistance exercise compete for limited energy resources. To maximize anabolism it is necessary that protein synthesis occur both during and after exercise.

The only way to reduce fatigue and increase muscle protein synthesis is by increasing the level of ATP in muscle tissue. This can be accomplished either by exogenous administration of ATP or by increasing endogenous production. But to minimize fatigue and maximize protein synthesis a strategy that employs both methods is probably optimal.

When energy states are low ATP is rationed and the factors required for the translation process of protein synthesis (tRNA, acetylating enzymes, ribosomes) are down regulated. It is during those times that increasing ATP through a vehicle such as Syntheselen™ may be of benefit.

In addition during periods when the body is not producing sufficient amounts of luteinizing hormone (a hormone which stimulates Leydig cell production of testosterone) the administration of both Adenosine Triphosphate (ATP) and Uridine Triphosphate (UTP) will result in binding to ATP receptors on gonadotropes. This appears to bring about a release of luteinizing hormone. This action raises the possibility that exogenous ATP and UTP could be utilized as an ancillary during the suppressive events of male hormone replacement therapy and difficult recovery period following hormone replacement therapy.

Why Syntheselen™?

The inclusion of Magnesium Aspartate in Syntheselen™ stabilizes ATP and without it ATP would quickly break down. Heptaminol increases extra and intracellular free calcium ion concentration 1 which should enable ATP and UTP to have a more pronounced effect on Luteinizing Hormone release. As a vasodilator Heptaminol should increase the amount of ATP & UTP available at the pituitary where ATP receptors on gonadotropes reside in addition to increasing muscular blood flow and amino acid & ATP transport and uptake. The anti-fatiguing effect of Potassium Aspartate 2 together with ATP-Magnesium Aspartate will increase productivity in resistance exercise and together with sufficient amino acid ingestion and carbohydrate intake and blood flow result in protein synthesis both during and after resistance exercise.

References:

1 – Peineau N, Mongo KG, Le Guennec JY, Garnier D, Argibay JA, Alteration of the L-type calcium current in guinea-pig single ventricular myocytes by heptaminol hydrochloride, Br J Pharmacol 107: 104–108 (1992)
2 – Formica PE,
The housewife syndrome. Treatment with the potassium and magnesium salts of aspartic acid, Curr Ther Res Clin Exp. 1962 Mar; 4: 98-106

 



ANABOLIC STEROIDS

 

  
© 2018 Musclefuture.com. All rights reserved.
  
Contact Us 
Shipping & Returns 
Terms & Conditions